Page last updated: 2024-10-22

amsacrine and Rectal Neoplasms

amsacrine has been researched along with Rectal Neoplasms in 2 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Rectal Neoplasms: Tumors or cancer of the RECTUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Omura, GA1
Bartolucci, AA1
Lessner, HE1
Hill, GJ1
Valdivieso, M1
Stroehlein, JR1
Bedikian, AY1
Karlin, DA1
Legha, SS1
Bennetts, RW1
Bodey, GP1

Other Studies

2 other studies available for amsacrine and Rectal Neoplasms

ArticleYear
Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial.
    Cancer treatment reports, 1984, Volume: 68, Issue:6

    Topics: Aminoacridines; Amsacrine; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Gastro

1984
Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
    American journal of clinical oncology, 1983, Volume: 6, Issue:1

    Topics: Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Bone Marrow; Colonic Neoplasms; Drug

1983